Curating from trusted global sources…
21 briefings · “ants”
A culturally adapted lifestyle trial delivers a bigger brain-function bump by targeting risk factors participants actually have.
A six-month trial suggests one fruit serving a day may measurably shift heart-disease risk markers.
A 2026 reality check: modern rendering can hide low frame rates without smearing the whole screen.
The latest Ceuta surge flips the 2021 crisis timeline, and EU leaders are pushing emergency interior talks over border controls.
Heat and water shortages push UK buyers to import lettuce and broccoli from Spain, reshaping food-cost risk across retail and restaurants.
Lovable, Replit, and others are raising billions as Big Tech both bets on and panics about AI-built software.
The ChatGPT maker’s filing joins Anthropic’s AI listing wave and turns “someday” into a real timing option.
SpaceX wants to raise up to $75bn at $135 a share, but critics say the fixed-price deal may leave buyers overpaying before book building even starts.
A fixed $135 IPO roadshow price would put SpaceX at $1.75 trillion, a milestone that reshuffles how founders, boards, and public-market investors compare private and listed giants.
